Company intelligence / Profile preview
QurCan Therapeutics
Toronto or Mississauga area inferred from context; exact city not explicitly stated in all sources., Ontario, Canadaqurcan.com ↗
- Ownership
- Private
- Development stage
- Preclinical
01
Overview
QurCan Therapeutics has developed a next-generation hybrid polymer-lipid nanoparticle platform called TERP that enables safe and tissue-selective delivery of biologic drugs—including RNAs, peptides, and antibodies—to extra-hepatic sites such as the brain and spleen. The company’s technology addresses challenges with current lipid nanoparticles by improving drug release profiles and reducing liver accumulation. Their lead programs are focused on precision medicine for solid-tumor cancer therapy and CNS diseases. As of 2024–2025 public sources indicate preclinical development; no clinical trial results have been published yet
- Therapeutic areas
- OncologyNeurology
- Modalities
- nanoparticle drug deliveryRNA therapeuticspeptidesantibodies
- Industry
- Biotech
02
Drug pipeline
1 assetBeyond the preview
Go deeper on QurCan Therapeutics.
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Licensing & deals
Full profile accessExplore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Full profile accessTrace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Full profile accessCompare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Full profile accessExplore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Full profile accessConnect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on QurCan Therapeutics.